These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 33254069

  • 1. Design, synthesis and stepwise optimization of nitrile-based inhibitors of cathepsins B and L.
    Cianni L, Rocho FDR, Bonatto V, Martins FCP, Lameira J, Leitão A, Montanari CA, Shamim A.
    Bioorg Med Chem; 2021 Jan 01; 29():115827. PubMed ID: 33254069
    [Abstract] [Full Text] [Related]

  • 2. Arylamine based cathepsin K inhibitors: investigating P3 heterocyclic substituents.
    Shinozuka T, Shimada K, Matsui S, Yamane T, Ama M, Fukuda T, Taki M, Takeda Y, Otsuka E, Yamato M, Naito S.
    Bioorg Med Chem; 2006 Oct 15; 14(20):6807-19. PubMed ID: 16829073
    [Abstract] [Full Text] [Related]

  • 3. Potent and selective cathepsin K inhibitors.
    Shinozuka T, Shimada K, Matsui S, Yamane T, Ama M, Fukuda T, Taki M, Takeda Y, Otsuka E, Yamato M, Mochizuki S, Ohhata K, Naito S.
    Bioorg Med Chem; 2006 Oct 15; 14(20):6789-806. PubMed ID: 16842999
    [Abstract] [Full Text] [Related]

  • 4. N-Sulfonyl dipeptide nitriles as inhibitors of human cathepsin S: In silico design, synthesis and biochemical characterization.
    Lemke C, Cianni L, Feldmann C, Gilberg E, Yin J, Dos Reis Rocho F, de Vita D, Bartz U, Bajorath J, Montanari CA, Gütschow M.
    Bioorg Med Chem Lett; 2020 Sep 15; 30(18):127420. PubMed ID: 32763808
    [Abstract] [Full Text] [Related]

  • 5. Highly Selective Sub-Nanomolar Cathepsin S Inhibitors by Merging Fragment Binders with Nitrile Inhibitors.
    Schade M, Merla B, Lesch B, Wagener M, Timmermanns S, Pletinckx K, Hertrampf T.
    J Med Chem; 2020 Oct 22; 63(20):11801-11808. PubMed ID: 32880457
    [Abstract] [Full Text] [Related]

  • 6. 2,5-Diaryloxadiazoles and their precursors as novel inhibitors of cathepsins B, H and L.
    Garg S, Raghav N.
    Bioorg Chem; 2016 Aug 22; 67():64-74. PubMed ID: 27285276
    [Abstract] [Full Text] [Related]

  • 7. Identification of new peptide amides as selective cathepsin L inhibitors: the first step towards selective irreversible inhibitors?
    Torkar A, Lenarčič B, Lah T, Dive V, Devel L.
    Bioorg Med Chem Lett; 2013 May 15; 23(10):2968-73. PubMed ID: 23562595
    [Abstract] [Full Text] [Related]

  • 8. Discovery and kinetic evaluation of 6-substituted 4-benzylthio-1,3,5-triazin-2(1H)-ones as inhibitors of cathepsin B.
    Sosič I, Mirković B, Turk S, Štefaneb B, Kos J, Gobec S.
    Eur J Med Chem; 2011 Sep 15; 46(9):4648-56. PubMed ID: 21849222
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of cathepsin L-like proteases by cathepsin V propeptide.
    Burden RE, Snoddy P, Jefferies CA, Walker B, Scott CJ.
    Biol Chem; 2007 May 15; 388(5):541-5. PubMed ID: 17516850
    [Abstract] [Full Text] [Related]

  • 10. A novel class of nonpeptidic biaryl inhibitors of human cathepsin K.
    Robichaud J, Oballa R, Prasit P, Falgueyret JP, Percival MD, Wesolowski G, Rodan SB, Kimmel D, Johnson C, Bryant C, Venkatraman S, Setti E, Mendonca R, Palmer JT.
    J Med Chem; 2003 Aug 14; 46(17):3709-27. PubMed ID: 12904076
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Design, synthesis, and biological evaluation of potent thiosemicarbazone based cathepsin L inhibitors.
    Kishore Kumar GD, Chavarria GE, Charlton-Sevcik AK, Arispe WM, Macdonough MT, Strecker TE, Chen SE, Siim BG, Chaplin DJ, Trawick ML, Pinney KG.
    Bioorg Med Chem Lett; 2010 Feb 15; 20(4):1415-9. PubMed ID: 20089402
    [Abstract] [Full Text] [Related]

  • 13. Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins.
    Plegge T, Spiegel M, Krüger N, Nehlmeier I, Winkler M, González Hernández M, Pöhlmann S.
    PLoS One; 2019 Feb 15; 14(4):e0214968. PubMed ID: 30973897
    [Abstract] [Full Text] [Related]

  • 14. Cathepsin B and L inhibitors: a patent review (2010 - present).
    Li YY, Fang J, Ao GZ.
    Expert Opin Ther Pat; 2017 Jun 15; 27(6):643-656. PubMed ID: 27998201
    [Abstract] [Full Text] [Related]

  • 15. Some thiocarbamoyl based novel anticathepsin agents.
    Kaur R, Raghav N.
    Bioorg Chem; 2020 Nov 15; 104():104174. PubMed ID: 32932119
    [Abstract] [Full Text] [Related]

  • 16. Quinazoline derivatives as cathepsins B, H and L inhibitors and cell proliferating agents.
    Raghav N, Jangra S, Kumar A, Bhattacharyya S.
    Int J Biol Macromol; 2017 Jan 15; 94(Pt A):719-727. PubMed ID: 27780761
    [Abstract] [Full Text] [Related]

  • 17. Human papillomavirus type 16 does not require cathepsin L or B for infection.
    Calton CM, Schlegel AM, Chapman JA, Campos SK.
    J Gen Virol; 2013 Aug 15; 94(Pt 8):1865-1869. PubMed ID: 23677785
    [Abstract] [Full Text] [Related]

  • 18. Prognostic significance of cathepsins B and L in primary human breast cancer.
    Foekens JA, Kos J, Peters HA, Krasovec M, Look MP, Cimerman N, Meijer-van Gelder ME, Henzen-Logmans SC, van Putten WL, Klijn JG.
    J Clin Oncol; 1998 Mar 15; 16(3):1013-21. PubMed ID: 9508185
    [Abstract] [Full Text] [Related]

  • 19. Arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 2: Optimization of P1 and N-aryl.
    Alper PB, Liu H, Chatterjee AK, Nguyen KT, Tully DC, Tumanut C, Li J, Harris JL, Tuntland T, Chang J, Gordon P, Hollenbeck T, Karanewsky DS.
    Bioorg Med Chem Lett; 2006 Mar 15; 16(6):1486-90. PubMed ID: 16412634
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.